IMPORTANT NOTE: This temporary page will soon be replaced by a permanent home page that is currently being developed by KGL PubFactory. The url for that new home page will be https://genomicpress.kglmeridian.com/. When that website is fully set up, all the content provided here will migrate there. Currently, our DOI links are not yet operational. They will become operational after our migration to https://genomicpress.kglmeridian.com/.
Early View: Advance Online Publishing (AOP)
As a service to our readers, in this section we publish online final, accepted, fully formatted articles for early view, before they are assigned to a specific journal issue. As all our content is Open Access, a list of articles is provided for download by readers. To view the final, accepted AOP PDF’s, please click on the article title hyperlinks provided below.
INAUGURAL EDITORIAL – Brain Medicine: Exceptional science, no fiefdoms, and a better tomorrow.
INAUGURAL GUEST EDITORIAL – Interventional Brain Medicine: Medicine’s newest frontier.
INNOVATORS & IDEAS: RISING STAR – Ruth M. Barrientos: Vulnerabilities associated with the aging brain that make it more susceptible to inflammatory challenges leading to memory dysfunction.
INNOVATORS & IDEAS: RISING STAR – Alessandra Borsini: What neuroinflammation has to do with depression and how nutrition can play a beneficial role.
INNOVATORS & IDEAS: RISING STAR – Andrea Ballesio: Mechanisms of sleep-mood interactions.
INNOVATORS & IDEAS: RISING STAR – Charlotte Steenblock: How does stress impact stem cells of the hypothalamic-pituitary-adrenal axis?
INNOVATORS & IDEAS: RISING STAR – Nathaniel G. Harnett: Identifying the neurobiological mechanisms of susceptibility to trauma and stress-related disorders.
INNOVATORS & IDEAS: RISING STAR – Daniel H. Wolf: Understanding motivation impairment from clinical, behavioral, and neurobiological perspectives to pave the way for better treatments
INNOVATORS & IDEAS: RESEARCH LEADER – Edythe London: Translating knowledge from molecular and functional imaging studies to new pharmacological and brain stimulation treatments for addiction.
INNOVATORS & IDEAS: RESEARCH LEADER – Keqiang Ye: The C/EBPb/AEP pathway is the key driver for Alzheimer’s disease (AD) and Parkinson’s disease (PD) pathogenesis and its specific inhibitor attenuates AD/PD pathologies.
INNOVATORS & IDEAS: RESEARCH LEADER – Michele T. Pato: Nature and nurture are essential to living the fullest and most enjoyable life; it is never just about our genes but what you do with them and what you bring to the table.
INNOVATORS & IDEAS: RESEARCH LEADER – Udo Dannlowski: Brain structure and function in the long-term course of mental disorders.
INNOVATORS & IDEAS: RESEARCH LEADER – Kim Q. Do: Antioxidants specifically targeted at mitochondria: A novel therapeutic approach to schizophrenia.
INNOVATORS & IDEAS: RESEARCH LEADER – Károly Mirnics: Many medications and chemicals might not be as safe for the developing brain as we think they are; this will greatly depend on your genotype, habits, and environmental factors.
INNOVATORS & IDEAS: RESEARCH LEADER – Carmine Maria Pariante: Understanding why and how stress makes us ill.
INNOVATORS & IDEAS: RESEARCH LEADER – Tatia Lee: Neuropsychology and human neuroscience research insights inform the theoretical and translational framework for fostering brain and psychological health.
INNOVATORS & IDEAS: RESEARCH LEADER – Stefan R. Bornstein: Stress, diabetes, and depression.
INNOVATORS & IDEAS: RESEARCH LEADER – Paola Dazzan: What can we do to understand psychosis?
INNOVATORS & IDEAS: RESEARCH LEADER – Euripedes C. Miguel: Risk factors for obsessive-compulsive and other mental health disorders and their treatment and public policy implications.
INNOVATORS & IDEAS: RESEARCH LEADER – Hermona Soreq: Revolutionizing neuroscience by elucidating the roles of poly(A) tails, mRNA stability, and acetylcholine in brain-body communication throughout the lifespan.
INNOVATORS & IDEAS: RESEARCH LEADER – Alysson Muotri: Modeling the human brain with stem cells and organoids, from disease paradigms to neanderthoids, space brains, and beyond.
INNOVATORS & IDEAS: RESEARCH LEADER – Illana Gozes: From the pivotal discovery of activity-dependent neuroprotective protein (ADNP) through its investigational drug davunetide: brain molecular medicine providing hope for autism, schizophrenia and Alzheimer’s disease.
INNOVATORS & IDEAS: RESEARCH LEADER – Celso Arango: The future of psychiatry inevitably depends on primary prevention.
INNOVATORS & IDEAS: RESEARCH LEADER – Carlos A. Zarate, Jr.: Using clinical translational neuroscience to develop the next generation of antidepressant treatments that act more rapidly and effectively.
VIEWPOINT – Gold PW: Depression: A malady of the self, arising from stress responses gone awry.
BENCH TO BEDSIDE – Song X & Gustafsson J-Å: Therapeutic potential of liver X receptor beta in depression and anxiety.
PERSPECTIVE – Steenblock C, et al: A multimodal approach for treating post-acute infectious syndrome.
BREVIA – Wong M-L et al: A novel animal paradigm of long-term, stress-induced hippocampal atrophy.
BREVIA – Grieco SF et al: Internet searches for ADHD medications surged during the COVID-19 pandemic.
RESEARCH REPORT – Gonçalves JPF et al.: The association of different acute manifestations of multiple sclerosis on functional outcome.
RESEARCH REPORT – Melo HM et al: Ultra-short heart rate variability reliability for cardiac autonomic tone assessment in severe traumatic brain injury.